U.S. Patent to Protect More Efficient Buprenorphine Production
River Stone Biotech Inc. Announces Issuance of U.S. Patent to Protect Their More Efficient Buprenorphine Production Process.
Series B Fundraise Closes
River Stone Biotech Inc. Announces $6.8M Series B Financing to Advance Lead Pipeline Projects. Goal: To Treat Opiate Use Disorder and Opiate Overdose